Stage III Pancreatic Cancer AJCC v8

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB00062	Albumin human	0	Withdrawn	1
DB11363	Alectinib	0	Withdrawn	1
DB12015	Alpelisib	0	Withdrawn	1
DB01217	Anastrozole	0	Withdrawn	1
DB11595	Atezolizumab	0	Withdrawn	1
DB18028	Azenosertib	0	Recruiting	1
DB00112	Bevacizumab	0	Withdrawn	1
DB01101	Capecitabine	0	Withdrawn	1
DB00958	Carboplatin	0	Withdrawn	1
DB05239	Cobimetinib	0	Recruiting	1
DB05239	Cobimetinib	0	Withdrawn	1
DB11986	Entrectinib	0	Withdrawn	1
DB08871	Eribulin	0	Withdrawn	1
DB00947	Fulvestrant	0	Withdrawn	1
DB06205	Hyaluronidase (human recombinant)	0	Withdrawn	1
DB00762	Irinotecan	0	Withdrawn	1
DB01006	Letrozole	0	Withdrawn	1
DB11793	Niraparib	0	Withdrawn	1
DB09074	Olaparib	0	Recruiting	1
DB09074	Olaparib	0	Withdrawn	1
DB15110	Onvansertib	0	Recruiting	1
DB01229	Paclitaxel	0	Withdrawn	1
DB09073	Palbociclib	0	Withdrawn	1
DB06366	Pertuzumab	0	Withdrawn	1
DB00072	Trastuzumab	0	Withdrawn	1
DB05773	Trastuzumab emtansine	0	Withdrawn	1
DB08881	Vemurafenib	0	Withdrawn	1
DB00361	Vinorelbine	0	Withdrawn	1
DB08828	Vismodegib	0	Withdrawn	1
DB12001	Abemaciclib	1	Terminated	1
DB05812	Abiraterone	1	Terminated	1
DB08916	Afatinib	1	Terminated	1
DB00062	Albumin human	1	Recruiting	2
DB00062	Albumin human	1	Terminated	1
DB14809	Anetumab ravtansine	1	Active Not Recruiting	1
DB00023	Asparaginase Escherichia coli	1	Recruiting	1
DB09495	Avobenzone	1	Terminated	1
DB11105	Benzalkonium	1	Recruiting	1
DB11794	Berzosertib	1	Active Not Recruiting	1
DB00112	Bevacizumab	1	Terminated	1
DB01128	Bicalutamide	1	Terminated	1
DB00188	Bortezomib	1	Terminated	1
DB16741	Bortezomib D-mannitol	1	Terminated	1
DB00559	Bosentan	1	Recruiting	1
DB06772	Cabazitaxel	1	Terminated	1
DB08875	Cabozantinib	1	Terminated	1
DB14730	Calaspargase pegol	1	Recruiting	1
DB01373	Calcium	1	Completed	1
DB04690	Camptothecin	1	Active Not Recruiting	2
DB01101	Capecitabine	1	Terminated	1
DB14531	Carbonate ion	1	Recruiting	1
DB00958	Carboplatin	1	Terminated	1
DB00482	Celecoxib	1	Terminated	1
DB05239	Cobimetinib	1	Recruiting	1
DB05239	Cobimetinib	1	Terminated	1
DB12483	Copanlisib	1	Terminated	1
DB08912	Dabrafenib	1	Terminated	1
DB11963	Dacomitinib	1	Terminated	1
DB12941	Darolutamide	1	Terminated	1
DB01254	Dasatinib	1	Terminated	1
DB00694	Daunorubicin	1	Terminated	1
DB15627	Dostarlimab	1	Recruiting	1
DB00997	Doxorubicin	1	Terminated	1
DB11714	Durvalumab	1	Suspended	1
DB11714	Durvalumab	1	Terminated	1
DB18060	Emavusertib	1	Recruiting	1
DB13874	Enasidenib	1	Terminated	1
DB11841	Entinostat	1	Withdrawn	1
DB11986	Entrectinib	1	Terminated	1
DB08899	Enzalutamide	1	Terminated	1
DB00530	Erlotinib	1	Terminated	1
DB01590	Everolimus	1	Terminated	1
DB00544	Fluorouracil	1	Terminated	1
DB00441	Gemcitabine	1	Active Not Recruiting	2
DB00441	Gemcitabine	1	Recruiting	2
DB09054	Idelalisib	1	Terminated	1
DB00619	Imatinib	1	Terminated	1
DB06186	Ipilimumab	1	Active Not Recruiting	1
DB06186	Ipilimumab	1	Terminated	1
DB00762	Irinotecan	1	Active Not Recruiting	2
DB09078	Lenvatinib	1	Terminated	1
DB00650	Leucovorin	1	Terminated	1
DB12130	Lorlatinib	1	Terminated	1
DB00678	Losartan	1	Active Not Recruiting	1
DB00678	Losartan	1	Terminated	1
DB16239	Molibresib	1	Withdrawn	1
DB11828	Neratinib	1	Terminated	1
DB11793	Niraparib	1	Recruiting	1
DB09035	Nivolumab	1	Active Not Recruiting	1
DB09035	Nivolumab	1	Terminated	1
DB09496	Octinoxate	1	Terminated	1
DB09074	Olaparib	1	Suspended	1
DB09074	Olaparib	1	Terminated	1
DB00526	Oxaliplatin	1	Terminated	1
DB01229	Paclitaxel	1	Recruiting	2
DB01229	Paclitaxel	1	Terminated	1
DB09073	Palbociclib	1	Terminated	1
DB06603	Panobinostat	1	Terminated	1
DB09037	Pembrolizumab	1	Terminated	1
DB06366	Pertuzumab	1	Terminated	1
DB08901	Ponatinib	1	Terminated	1
DB08896	Regorafenib	1	Terminated	1
DB08877	Ruxolitinib	1	Terminated	1
DB15366	SOR-C13	1	Completed	1
DB00877	Sirolimus	1	Terminated	1
DB00398	Sorafenib	1	Terminated	1
DB01268	Sunitinib	1	Terminated	1
DB01030	Topotecan	1	Active Not Recruiting	1
DB08911	Trametinib	1	Terminated	1
DB05773	Trastuzumab emtansine	1	Terminated	1
DB00755	Tretinoin	1	Terminated	1
DB08881	Vemurafenib	1	Terminated	1
DB11581	Venetoclax	1	Terminated	1
DB08828	Vismodegib	1	Terminated	1
DB02546	Vorinostat	1	Terminated	1
DB00062	Albumin human	1 / 2	Recruiting	1
DB11105	Benzalkonium	1 / 2	Suspended	1
DB01373	Calcium	1 / 2	Recruiting	1
DB04690	Camptothecin	1 / 2	Recruiting	1
DB11841	Entinostat	1 / 2	Recruiting	1
DB00544	Fluorouracil	1 / 2	Recruiting	1
DB00441	Gemcitabine	1 / 2	Recruiting	1
DB00762	Irinotecan	1 / 2	Recruiting	1
DB00650	Leucovorin	1 / 2	Recruiting	1
DB11596	Levoleucovorin	1 / 2	Recruiting	1
DB16252	Nedisertib	1 / 2	Suspended	1
DB00526	Oxaliplatin	1 / 2	Recruiting	1
DB01229	Paclitaxel	1 / 2	Recruiting	1
DB12257	Platinum	1 / 2	Recruiting	1
DB00062	Albumin human	2	Active Not Recruiting	1
DB11967	Binimetinib	2	Terminated	1
DB01373	Calcium	2	Recruiting	1
DB04690	Camptothecin	2	Recruiting	1
DB01101	Capecitabine	2	Recruiting	1
DB14547	Chloride ion	2	Active Not Recruiting	1
DB00515	Cisplatin	2	Active Not Recruiting	1
DB14825	Danvatirsen	2	Active Not Recruiting	1
DB12109	Devimistat	2	Recruiting	1
DB11714	Durvalumab	2	Active Not Recruiting	1
DB11718	Encorafenib	2	Terminated	1
DB11717	Epacadostat	2	Withdrawn	1
DB00544	Fluorouracil	2	Recruiting	2
DB00441	Gemcitabine	2	Active Not Recruiting	2
DB00441	Gemcitabine	2	Recruiting	1
DB01611	Hydroxychloroquine	2	Recruiting	1
DB00762	Irinotecan	2	Recruiting	1
DB09078	Lenvatinib	2	Recruiting	1
DB00650	Leucovorin	2	Recruiting	1
DB11596	Levoleucovorin	2	Recruiting	1
DB00166	Lipoic acid	2	Recruiting	1
DB00678	Losartan	2	Recruiting	1
DB00526	Oxaliplatin	2	Recruiting	1
DB01229	Paclitaxel	2	Active Not Recruiting	1
DB17284	Pelareorep	2	Terminated	1
DB09037	Pembrolizumab	2	Recruiting	1
DB09037	Pembrolizumab	2	Terminated	1
DB09037	Pembrolizumab	2	Withdrawn	1
DB12257	Platinum	2	Active Not Recruiting	1
DB11760	Talazoparib	2	Recruiting	1
DB12095	Telotristat ethyl	2	Active Not Recruiting	1
DB07232	Veliparib	2	Active Not Recruiting	1
DB00460	Verteporfin	2	Completed	1